Acadian Asset Management LLC Bristol Myers Squibb CO Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Acadian Asset Management LLC holds 290,567 shares of BMY stock, worth $16.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

290,567

Previous 347,374 16.35%

Holding current value

$16.8 Million

Previous $14.4 Million 4.23%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $2.25 Million - $2.94 Million	-56,807 Reduced 16.35%	290,567 $15 Million
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $11 Million - $14.5 Million	-272,950 Reduced 44.0%	347,374 $14.4 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $12.9 Million - $14.6 Million	268,006 Added 76.07%	620,324 $33.6 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $19.9 Million - $23.7 Million	-410,363 Reduced 53.81%	352,318 $18.1 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $21.5 Million - $24 Million	-371,495 Reduced 32.75%	762,681 $44.3 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $20.9 Million - $23.2 Million	-328,058 Reduced 22.44%	1,134,176 $72.5 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $17.1 Million - $19.4 Million	260,092 Added 21.64%	1,462,234 $101 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.09 Million - $1.29 Million	15,862 Added 1.34%	1,202,142 $86.5 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $116,038 - $68.6 Million	892,600 Added 303.94%	1,186,280 $84.3 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $20 Million - $22.1 Million	276,011 Added 1562.12%	293,680 $22.6 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $820,696 - $984,088	13,349 Added 309.0%	17,669 $1.29 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $563,879 - $668,560	-13,184 Reduced 75.32%	4,320 $219,000
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $1.4 Million - $1.55 Million	-31,449 Reduced 64.24%	17,504 $794,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $1.53 Million - $1.83 Million	-33,992 Reduced 40.98%	48,953 $2.34 Million
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $2.31 Million - $3 Million	47,426 Added 133.52%	82,945 $4.31 Million
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $9.73 Million - $11 Million	-176,268 Reduced 83.23%	35,519 $2.2 Million
Q2 2018 Jul 24, 2018	BUY	$50.53 - $62.98 $9.87 Million - $12.3 Million	195,381 Added 1190.91%	211,787 $11.7 Million
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $196,477 - $226,185	-3,279 Reduced 16.66%	16,406 $1.04 Million
Q4 2017 Jan 18, 2018	SELL	$59.94 - $65.35 $723,355 - $788,643	-12,068 Reduced 38.01%	19,685 $1.21 Million
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $1.75 Million - $2.02 Million	31,753	31,753 $2.02 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Bristol Myers Squibb CO Transaction History